Form 4 filings across 1 company. Net figures count open-market buys and sales only. EDGAR profile ↗
Lifetime net: $0
Reported holding is the most recent post-transaction share count on a Table I row.
How quickly this filer reports. Section 16 allows two business days from the transaction.
No filings held for this insider can be measured against the deadline.
The 12 most recent Form 4 transactions.
| Apellis Pharmaceuticals,… |
| DTOISS◆ |
| 7,441 |
| — |
| — |
| — |
| Open the original filing on SEC.gov |
| May 14 | APLS | Apellis Pharmaceuticals,… | DTOISS◆ | 8,554 | — | — | — | Open the original filing on SEC.gov |
| May 14 | APLS | Apellis Pharmaceuticals,… | DTOISS◆ | 11,199 | — | — | — | Open the original filing on SEC.gov |
| May 14 | APLS | Apellis Pharmaceuticals,… | DTOISS◆ | 27,600 | — | — | — | Open the original filing on SEC.gov |
| May 14 | APLS | Apellis Pharmaceuticals,… | DTOISS◆ | 14,684 | — | — | — | Open the original filing on SEC.gov |
| May 14 | APLS | Apellis Pharmaceuticals,… | DTOISS | 3,544 | — | — | -100.0% | Open the original filing on SEC.gov |
| May 14 | APLS | Apellis Pharmaceuticals,… | DTOISS | 7,961 | — | — | -100.0% | Open the original filing on SEC.gov |
| May 14 | APLS | Apellis Pharmaceuticals,… | DTOISS | 5,744 | — | — | -100.0% | Open the original filing on SEC.gov |
| May 14 | APLS | Apellis Pharmaceuticals,… | DTOISS | 3,062 | — | — | -100.0% | Open the original filing on SEC.gov |
| May 14 | APLS | Apellis Pharmaceuticals,… | UTENDR | 161,567 | — | — | -100.0% | Open the original filing on SEC.gov |